EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sodium Butyrate, A Gut Microbiota Derived Metabolite in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review

Zeynab Sarlak, Narges Naderi, Bardia Amidi, Vajihe Ghorbanzadeh

Cardiovascular & Hematological Agents in Medicinal Chemistry · 2025-01 · 23 (1) · 1-10

DOI: 10.2174/0118715257307380240820052940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular & Hematological Agents in Medicinal Chemistry, 2025-01. Verfasst von Zeynab Sarlak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Khorramabad branch, Islamic Azad University, Khorramabad, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Cardiovascular Diseases, Butyric Acid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 131 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes is characterized by elevated blood glucose levels, leading to an increased risk of cardiovascular diseases. Sodium butyrate, the sodium salt of the short-chain fatty acid butyric acid produced by gut microbiota fermentation, has shown promising effects on metabolic diseases, including type 2 diabetes and cardiovascular diseases. Sodium butyrate demonstrates anti-inflammatory, anti-oxidative, and lipid-lowering properties and can improve insulin sensitivity and reduce hepatic steatosis. In this review, we investigate how sodium butyrate influences cardiovascular complications of type 2 diabetes, including atherosclerosis (AS), heart failure (HF), hypertension, and angiogenesis. Moreover, we explore the pathophysiology of cardiovascular disease in type 2 diabetes, focusing on hyperglycemia, oxidative stress, inflammation, and genetic factors playing crucial roles. The review suggests that sodium butyrate can be a potential preventive and therapeutic agent for cardiovascular complications in individuals with type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeCardiovascular DiseasesButyric AcidHumansAnimals

Stichwörter der Autor:innen

Type 2 diabetescardiovascular diseasefermentationhyperglycemia.microbiotasodium butyrate

Substanzen

Butyric Acid

Autor:innen und Institutionen

  • Department of Biology, Khorramabad branch, Islamic Azad University, Khorramabad, Iran.
  • Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran.

Zitieren

APA

Sarlak, Z., Naderi, N., Amidi, B., & Ghorbanzadeh, V. (2025). Sodium Butyrate, A Gut Microbiota Derived Metabolite in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review. Cardiovascular & Hematological Agents in Medicinal Chemistry, 23(1), 1-10. https://doi.org/10.2174/0118715257307380240820052940

Vancouver

Sarlak Z, Naderi N, Amidi B, Ghorbanzadeh V. Sodium Butyrate, A Gut Microbiota Derived Metabolite in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review. Cardiovascular & Hematological Agents in Medicinal Chemistry. 2025;23(1):1-10. doi:10.2174/0118715257307380240820052940

BibTeX
@article{Sarlak2025,
  author = {Sarlak, Zeynab and Naderi, Narges and Amidi, Bardia and Ghorbanzadeh, Vajihe},
  title = {Sodium Butyrate, A Gut Microbiota Derived Metabolite in Type 2 Diabetes Mellitus and Cardiovascular Disease: A Review},
  journal = {Cardiovascular & Hematological Agents in Medicinal Chemistry},
  year = {2025},
  volume = {23},
  number = {1},
  pages = {1--10},
  doi = {10.2174/0118715257307380240820052940}
}
Kostenlos starten →